We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
SkinHealth Systems Inc. (SKIN) International Revenue Performance Explored
Read MoreHide Full Article
Have you assessed how the international operations of SkinHealth Systems Inc. (SKIN - Free Report) performed in the quarter ended June 2026? For this company, possessing an expansive global footprint, parsing the trends of international revenues could be critical to gauge its financial resilience and growth prospects.
In the current global economy, which is more interconnected than ever, a company's success in penetrating international markets is crucial for its financial health and growth journey. Investors must understand a company's dependence on overseas markets, as this offers a window into the company's earnings stability, its ability to benefit from varied economic cycles and its potential for long-term growth.
Participation in global economies acts as a defense against economic difficulties at home and a pathway to more rapidly developing economies. However, it also comes with the complexities of dealing with fluctuating currencies, geopolitical risks and different market dynamics.
While delving into SKIN's performance for the past quarter, we observed some fascinating trends in the revenue from its foreign segments that are commonly modeled and observed by analysts on Wall Street.
The company's total revenue for the quarter amounted to $72.1 million, showing decrease of 7.8%. We will now explore the breakdown of SKIN's overseas revenue to assess the impact of its international operations.
Trends in SKIN's Revenue from International Markets
Of the total revenue, $14.9 million came from EMEA during the last fiscal quarter, accounting for 20.7%. This represented a surprise of -16.78% as analysts had expected the region to contribute $17.91 million to the total revenue. In comparison, the region contributed $13.7 million, or 21.1%, and $18.4 million, or 23.5%, to total revenue in the previous and year-ago quarters, respectively.
Asia Pacific generated $7.3 million in revenues for the company in the last quarter, constituting 10.1% of the total. This represented a surprise of +7.75% compared to the $6.78 million projected by Wall Street analysts. Comparatively, in the previous quarter, Asia Pacific accounted for $6.6 million (10.2%), and in the year-ago quarter, it contributed $7.7 million (9.9%) to the total revenue.
Prospective Revenues in International Markets
It is projected by analysts on Wall Street that SkinHealth Systems Inc. will post revenues of $67.3 million for the ongoing fiscal quarter, a decline of 4.8% from the year-ago quarter. The expected contributions from EMEA and Asia Pacific to this revenue are 23.9%, and 8.9%, translating into $16.1 million, and $6.01 million, respectively.
Analysts expect the company to report a total annual revenue of $285.81 million for the full year, marking a decrease of 5% compared to last year. The expected revenue contributions from EMEA and Asia Pacific are projected to be 23% ($65.79 million), and 9% ($25.62 million) of the total revenue, in that order.
In Conclusion
SkinHealth Systems Inc.'s leaning on foreign markets for its revenue stream presents a mix of chances and challenges. Therefore, a vigilant watch on its international revenue movements can greatly aid in projecting the company's future direction.
In a world where international interdependencies and geopolitical conflicts are ever-increasing, Wall Street analysts closely monitor these trends for companies having international presence to adjust their earnings forecasts. Of course, there are several other factors, including a company's standing within its home borders, that influence analysts' earnings forecasts.
Here at Zacks, we put a great deal of emphasis on a company's changing earnings outlook, as empirical research has shown that's a powerful force driving a stock's near-term price performance. Quite naturally, the correlation is positive here -- an upward revision in earnings estimates drives the stock price higher.
The Zacks Rank, our proprietary stock rating mechanism, demonstrates a notable performance history confirmed through external audits. It effectively utilizes the power of earnings estimate revisions to act as a predictor of a stock's price performance in the near term.
Examining the Latest Trends in SkinHealth Systems Inc.'s Stock Value
Over the past month, the stock has lost 23.9% versus the Zacks S&P 500 composite's 2.5% increase. The Zacks Medical sector, of which SkinHealth Systems Inc. is a part, has risen 3.3% over the same period. The company's shares have increased 5.7% over the past three months compared to the S&P 500's 5.1% increase. Over the same period, the sector has risen 12.9%
View the Zacks #1 Rank List
Image: Bigstock
SkinHealth Systems Inc. (SKIN) International Revenue Performance Explored
Have you assessed how the international operations of SkinHealth Systems Inc. (SKIN - Free Report) performed in the quarter ended June 2026? For this company, possessing an expansive global footprint, parsing the trends of international revenues could be critical to gauge its financial resilience and growth prospects.
In the current global economy, which is more interconnected than ever, a company's success in penetrating international markets is crucial for its financial health and growth journey. Investors must understand a company's dependence on overseas markets, as this offers a window into the company's earnings stability, its ability to benefit from varied economic cycles and its potential for long-term growth.
Participation in global economies acts as a defense against economic difficulties at home and a pathway to more rapidly developing economies. However, it also comes with the complexities of dealing with fluctuating currencies, geopolitical risks and different market dynamics.
While delving into SKIN's performance for the past quarter, we observed some fascinating trends in the revenue from its foreign segments that are commonly modeled and observed by analysts on Wall Street.
The company's total revenue for the quarter amounted to $72.1 million, showing decrease of 7.8%. We will now explore the breakdown of SKIN's overseas revenue to assess the impact of its international operations.
Trends in SKIN's Revenue from International Markets
Of the total revenue, $14.9 million came from EMEA during the last fiscal quarter, accounting for 20.7%. This represented a surprise of -16.78% as analysts had expected the region to contribute $17.91 million to the total revenue. In comparison, the region contributed $13.7 million, or 21.1%, and $18.4 million, or 23.5%, to total revenue in the previous and year-ago quarters, respectively.
Asia Pacific generated $7.3 million in revenues for the company in the last quarter, constituting 10.1% of the total. This represented a surprise of +7.75% compared to the $6.78 million projected by Wall Street analysts. Comparatively, in the previous quarter, Asia Pacific accounted for $6.6 million (10.2%), and in the year-ago quarter, it contributed $7.7 million (9.9%) to the total revenue.
Prospective Revenues in International Markets
It is projected by analysts on Wall Street that SkinHealth Systems Inc. will post revenues of $67.3 million for the ongoing fiscal quarter, a decline of 4.8% from the year-ago quarter. The expected contributions from EMEA and Asia Pacific to this revenue are 23.9%, and 8.9%, translating into $16.1 million, and $6.01 million, respectively.Analysts expect the company to report a total annual revenue of $285.81 million for the full year, marking a decrease of 5% compared to last year. The expected revenue contributions from EMEA and Asia Pacific are projected to be 23% ($65.79 million), and 9% ($25.62 million) of the total revenue, in that order.
In Conclusion
SkinHealth Systems Inc.'s leaning on foreign markets for its revenue stream presents a mix of chances and challenges. Therefore, a vigilant watch on its international revenue movements can greatly aid in projecting the company's future direction.
In a world where international interdependencies and geopolitical conflicts are ever-increasing, Wall Street analysts closely monitor these trends for companies having international presence to adjust their earnings forecasts. Of course, there are several other factors, including a company's standing within its home borders, that influence analysts' earnings forecasts.
Here at Zacks, we put a great deal of emphasis on a company's changing earnings outlook, as empirical research has shown that's a powerful force driving a stock's near-term price performance. Quite naturally, the correlation is positive here -- an upward revision in earnings estimates drives the stock price higher.
The Zacks Rank, our proprietary stock rating mechanism, demonstrates a notable performance history confirmed through external audits. It effectively utilizes the power of earnings estimate revisions to act as a predictor of a stock's price performance in the near term.
SkinHealth Systems Inc., bearing a Zacks Rank #3 (Hold), is expected to mirror the broader market's movements in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Examining the Latest Trends in SkinHealth Systems Inc.'s Stock Value
Over the past month, the stock has lost 23.9% versus the Zacks S&P 500 composite's 2.5% increase. The Zacks Medical sector, of which SkinHealth Systems Inc. is a part, has risen 3.3% over the same period. The company's shares have increased 5.7% over the past three months compared to the S&P 500's 5.1% increase. Over the same period, the sector has risen 12.9%